发明名称 USE OF RGM AND ITS MODULATORS
摘要 The present invention relates to the use of a modulator of a polypeptide having or comprising an amino acid sequence as disclosed herein or of a functional fragment or derivative thereof or of a polynucleotide encoding said polypeptide or fragment or derivative for the preparation of a pharmaceutical composition for preventing, alleviating or treating diseases or conditions associated with the degeneration or injury of vertebrate nervous tissue, associated with seizures or associated with angiogenic disorders or disorders of the cardiovascular system. Furthermore, the invention provides for the use of a modulator of a polypeptide having or comprising said amino acid sequence of a functional fragment or derivative thereof or of a polynucleotide encoding said polypeptide or fragment or derivative for the preparation of a pharmaceutical composition for preventing, alleviating or treating diseases or conditions associated with the degeneration or injury of vertebrate nervous tissue, associated with angiogenic disorders or disorders of the cardiovascular system. In addition, the invention provides for the use of said polypeptide or said functional fragment or derivative thereof for the preparation of a pharmaceutical compositions for preventing or treating tumor growth or formation of tumor metastases or as a marker of stem cells.
申请公布号 US2011112280(A1) 申请公布日期 2011.05.12
申请号 US20100939823 申请日期 2010.11.04
申请人 MUELLER BERNHARD K;MONNIER PHILIPPE P;MACCHI PAOLO;BONHOEFFER FRIEDRICH;STAHL BERND;MANN MATTHIAS;ANDERSEN JENS S 发明人 MUELLER BERNHARD K.;MONNIER PHILIPPE P.;MACCHI PAOLO;BONHOEFFER FRIEDRICH;STAHL BERND;MANN MATTHIAS;ANDERSEN JENS S.
分类号 A61K48/00;C07K16/00;A61K31/7088;A61K38/00;A61K38/17;A61K39/395;A61P9/00;A61P9/10;A61P17/02;A61P25/00;A61P25/02;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P29/00;A61P31/04;A61P35/00;A61P37/00;A61P37/08;A61P43/00;C07H21/04;C07K14/00;C07K14/47;C07K16/28 主分类号 A61K48/00
代理机构 代理人
主权项
地址